IBM partners with pharmaceutical and life sciences industry leaders to create IBM Cognos Performance Blueprints. Blueprints provide streamlined planning, forecasting, analysis and reporting functionality. They enable organizations to quickly align strategic objectives, operational plans, people and activities. Most importantly, they help drive faster ROI and reduce total cost of ownership.
Blueprints for the pharmaceutical and life sciences sector include:
Palladium-IBM Cognos Integrated Brand Management Performance Blueprint.
The Integrated Brand Management Blueprint helps brand and therapeutic area managers ensure successful product launches, enhance go-to-market productivity and maximize brand value.
IBM Cognos Clinical Trial Enrollment Forecasting Performance Blueprint.
The Clinical Trial Enrollment Forecasting Blueprint provides insight into enrollment indicators that can affect the progress of costly clinical trials, to ensure adequate patient participation and facilitate collaboration among all stakeholders.
IBM Cognos Clinical Trial Forecasting Performance Blueprint.
The Clinical Trial Forecasting Blueprint helps pharmaceutical companies better anticipate clinical trial resource requirements and accompanying expenses in order to comply more quickly with FDA filing requirements.
IBM Cognos Sales Quota Allocation Performance Blueprint.
The Sales Quota Allocation Blueprint significantly reduces the time, overhead, complexity and cost of managing sales quota allocations, eliminating the need to reconcile hundreds of disparate spreadsheets.
IBM Cognos Sample Optimization Performance Blueprint.
The Sample Optimization Blueprint enables pharmaceutical executives to develop and implement sample allocation plans that are in line with corporate revenue objectives.